Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Income Tax Expense

$869.30M

TTM · Period ending: Jun 30, 2026 · USD

VRTX Income Tax Expense

Latest reported$869.30Mperiod endingJun 30, 2026

Latest reported$869.30Mperiod endingJun 30, 2026

VRTX TTM Income Tax ($0.00 → $869.30M)

TTM income tax expense

High-resolution chart · PNG

VRTX income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Income Tax Expense — Trailing twelve months (TTM) (USD)
Period ending	Income Tax Expense (USD)
Jun 30, 2001	14,000
Mar 31, 2001	-3,147,000
Dec 31, 2000	976,000
Sep 30, 2000	4,523,000
Jun 30, 2000	-4,763,000
Mar 31, 2000	-1,202,000
Dec 31, 1999	-1,600,000
Sep 30, 1999	-1,700,000
Jun 30, 1999	-1,900,000
Mar 31, 1999	-2,100,000
Dec 31, 1998	-3,200,000
Sep 30, 1998	-3,200,000
Jun 30, 1998	-3,200,000
Mar 31, 1998	-3,200,000
Dec 31, 1997	900,000
Sep 30, 1997	-1,000,000
Jun 30, 1997	-2,300,000
Mar 31, 1997	-2,500,000
Dec 31, 1996	-3,800,000
Sep 30, 1996	-700,000
Jun 30, 1996	-700,000
Mar 31, 1996	-2,000,000
Dec 31, 1995	-2,100,000
Sep 30, 1995	-7,100,000
Jun 30, 1995	-5,800,000
Mar 31, 1995	-4,400,000
Dec 31, 1994	-3,200,000
Sep 30, 1994	200,000
Jun 30, 1994	-200,000
Mar 31, 1994	-100,000
Dec 31, 1993	-300,000
Sep 30, 1993	0
Jun 30, 1993	-200,000
Mar 31, 1993	-800,000
Dec 31, 1992	-1,100,000
Sep 30, 1992	-1,300,000
Jun 30, 1992	-1,100,000
Mar 31, 1992	-600,000
Dec 31, 1991	-100,000
Sep 30, 1991	-100,000
Jun 30, 1991	100,000
Mar 31, 1991	0
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.